Pricing Log in Create free account

Oculis Holding AG (OCS) vs ProKidney Corp. (PROK)

Oculis Holding AG and ProKidney Corp. are both Biotechnology companies. Oculis Holding AG and ProKidney Corp. are of similar size ($456.8M and $439.9M). Oculis Holding AG has the higher net margin (−6,870.1% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, ProKidney Corp. leads on 7 and Oculis Holding AG on 6.

Valuation

Metric OCS PROK Biotechnology median
P/E n/m n/m 8.50
P/S 303.32 303.33 9.71
P/B 1.61 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 108.92 81.78 9.21
Earnings yield (23.87%) (41.35%) (33.15%)
Free cash flow yield (18.51%) (57.04%) (25.50%)

Profitability

Metric OCS PROK Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (7,383.66%) (21,664.55%) 0.00%
Net margin (6,870.05%) (10,288.39%) 0.00%
Free cash flow margin (5,525.64%) (17,300.61%) 0.00%
Return on equity (44.87%) 8.92% (56.36%)
Return on assets (37.69%) (27.10%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCS PROK Biotechnology median
Revenue growth (TTM) 65.83% — 6.02%
EPS growth (last fiscal year) 5.39% 16.13% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric OCS PROK Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 8.35 8.36 4.72
Net debt to EBITDA 2.60 1.70 0.96

Dividend

Metric OCS PROK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OCS PROK Biotechnology median
Market cap 456.82m 439.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack